3 ML insulin lispro 100 UNT/ML Cartridge — RxCUI 1652644
RxNorm drug concept · Semantic clinical drug
RxCUI 1652644
Semantic clinical drug · SCD
● Current RxNorm concept 7 FDA products
10 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1652644
Official name3 ML insulin lispro 100 UNT/ML Cartridge
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asinsulin lispro 100 UNT/ML per 3 ML Cartridge; insulin lispro 100 UNT/ML in 3 ML Cartridge
FDA products mapped7
Package NDCs mapped10
Reported Medicaid activity (SDUD)623,090 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Insulin Lispro Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Insulin lispro is a fast-acting insulin that helps your body manage blood sugar around mealtimes. It works by helping your muscles and fat cells absorb glucose from your blood, whi...
- What exactly does insulin lispro do, and why did my doctor prescribe it?
- For subcutaneous injections, you should inject insulin lispro within 15 minutes before a meal or immediately after a meal. Because it acts quickly, timing really matters — injectin...
- When exactly should I inject this insulin — before or after I eat?
🕸️ Concept Web — How 3 ML insulin lispro 100 UNT/ML Cartridge Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
3 ML insulin lispro 100 UNT/ML Cartridge
RxCUI 1652644 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Insulin lispro
86009IN
-
Insulin lispro
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Humalog
135805BN
-
Humalog
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Insulin lispro Cartridge
1652643SCDF -
Insulin lispro Injectable Product
1157461SCDG -
Insulin lispro Cartridge [Humalog]
1652645SBDF -
Humalog Injectable Product
1171289SBDG -
Cartridge
1649572DF -
Injectable Product
1151126DFG
-
Insulin lispro Cartridge
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Insulin lispro 100 UNT/ML
343076SCDC -
3 ML insulin lispro 100 UNT/ML Cartridge [Humalog]
1652646SBD -
Insulin lispro 100 UNT/ML [Humalog]
575151SBDC
-
Insulin lispro 100 UNT/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Insulin lispro 100 UNT/ML
SCDC · 343076 -
Insulin lispro Cartridge
SCDF · 1652643 -
Insulin lispro Injectable Product
SCDG · 1157461
Brand-Name Concepts
-
3 ML insulin lispro 100 UNT/ML Cartridge [Humalog]
SBD · 1652646 -
Insulin lispro 100 UNT/ML [Humalog]
SBDC · 575151 -
Insulin lispro Cartridge [Humalog]
SBDF · 1652645 -
Humalog Injectable Product
SBDG · 1171289 -
Humalog
BN · 135805
📦 FDA Products & Package NDCs
7 products · 10 package NDCs
10 package NDCs map to RxCUI 1652644 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00002-0800-01 | 1 VIAL in 1 CARTON (0002-0800-01) / 10 mL in 1 VIAL | Sterile Diluent | Eli Lilly and Company | 1987-07-10 |
| 00002-7510-01 | 1 VIAL in 1 CARTON (0002-7510-01) / 10 mL in 1 VIAL | Humalog | Eli Lilly and Company | 1996-07-24 |
| 00002-7516-59 | 5 CARTRIDGE in 1 CARTON (0002-7516-59) / 3 mL in 1 CARTRIDG... | Humalog | Eli Lilly and Company | 2000-07-26 |
| 00002-7516-99 | 5 CARTRIDGE in 1 CARTON (0002-7516-99) / 3 mL in 1 CARTRIDG... | Humalog | Eli Lilly and Company | 2000-07-26 |
| 00002-7712-27 | 2 SYRINGE in 1 CARTON (0002-7712-27) / 3 mL in 1 SYRINGE (0... | Humalog KwikPen | Eli Lilly and Company | 2015-05-26 |
| 00002-7712-61 | 1 SYRINGE in 1 CARTON (0002-7712-61) / 3 mL in 1 SYRINGE | Humalog KwikPen | Eli Lilly and Company | 2017-10-01 |
| 00002-7714-59 | 5 SYRINGE in 1 CARTON (0002-7714-59) / 3 mL in 1 SYRINGE (0... | Humalog Junior KwikPen | Eli Lilly and Company | 2017-09-14 |
| 00002-7714-61 | 1 SYRINGE in 1 CARTON (0002-7714-61) / 3 mL in 1 SYRINGE | Humalog Junior KwikPen | Eli Lilly and Company | 2017-09-25 |
| 00002-8213-05 | 5 SYRINGE in 1 CARTON (0002-8213-05) / 3 mL in 1 SYRINGE (0... | Humalog Tempo Pen | Eli Lilly and Company | 2019-11-15 |
| 00002-8799-59 | 5 SYRINGE in 1 CARTON (0002-8799-59) / 3 mL in 1 SYRINGE (0... | Humalog KwikPen | Eli Lilly and Company | 2008-01-16 |
Observed labelers:
Eli Lilly and Company (10)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1817 | Insulin for insulin pump use | 4 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.